Imat 400 Mg (Imatinib)

✅ Key Benefits

• Higher dose suitable for resistant or advanced cases

• Targets critical kinases essential in tumor proliferation

• Proven clinical efficacy in achieving responses in CML and GIST

• Oral once-daily dosing equals convenience and adherence

• Flexible dosing allows dose escalation under medical supervision

🎯 How to Use

• Typically taken as 400 mg once daily, with or without food

• Swallow tablets whole with water—do not crush or chew

• Continue therapy until disease progression or intolerable toxicity

• Monitor complete blood counts, liver, renal, and cardiac function

• Dose adjustments or temporary interruptions may be based on tolerance and lab results

⚠️ Precautions

• Prescription-only under oncologist supervision

• Monitor for fluid retention, hepatotoxicity, myelosuppression

• Cardiac monitoring suggested due to rare heart failure risk

• Ensure effective contraception during treatment and 6 months after

• Check for drug interactions with CYP450 3A4 substrates or inhibitors

🤕 Possible Side Effects

• Common: Edema, nausea, diarrhea, muscle cramps, fatigue

• Hematologic: Neutropenia, thrombocytopenia, anemia

• Hepatic: Elevated liver enzymes, jaundice (rare)

• Cardiac: Occasional reports of cardiomyopathy or heart failure

• Other: Skin rash, headache, fever

❓ Frequently Asked Questions (FAQs)

Q. Why choose the 400 mg dose?
A. This dose is used for resistant or advanced disease where higher exposure offers better control.

Q. Can it be taken with meals?
A. Yes, with or without food. Consistency in timing is recommended.

Q. What monitoring is required?
A. Regular blood counts, liver and kidney tests, and cardiac evaluations are essential during therapy.

Q. How long is treatment?
A. Treatment is typically long-term, continuing as long as benefits outweigh risks and remission is maintained.